Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_930a111c087027bbd0e9607e2f27fce6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa6c0d1288cd918a9e88ed59485484f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_939c0a2954cb655d793b68b1dc6724fc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c927492d6ae28467d70ccf1e4941c673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7219b991dfc63d645df20d322cc98ffd |
publicationDate |
2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8802156-B2 |
titleOfInvention |
Pharmaceutical forms for the release of active compounds |
abstract |
A pharmaceutical composition containing a sulfated glycosaminoglycan drug and a polycationic polymer or copolymer wherein the proportion of ammonium groups in the pharmaceutical composition is between 0.01-2.0 μmol ammonium groups/mg pharmaceutical composition, the proportion of glycosaminoglycan in the pharmaceutical form is between 15% to 50% w/w, and the pharmaceutical composition possesses a moisture content of 10% wt or less. A pharmaceutical dosage form containing the pharmaceutical composition, and their use for the treatment of diseases or disorders therapeutically responsive to the glycosaminoglycan. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10809212-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10705037-B2 |
priorityDate |
2007-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |